You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Parsortix system identifies key drug targets in cancer metastasis

Liquid biopsy company Angle has announced the results of work undertaken in preclinical models of metastatic breast cancer (MBC), where specific genes involved in the metastatic process have been identified.